Clinical trial
Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain…
NCT00003563 · Pharmacyclics LLC., Industry · Completed
Key facts
| NCT number | NCT00003563 |
|---|---|
| Title | Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases |
| Official title | Phase III Randomized Trial of Gadolinium Texaphyrin (PCI-0120) Injection as a Radiation Sensitizer in Patients Receiving Whole Brain Radiation Therapy for the Treatment of Brain Metastases |
| Lead sponsor | Pharmacyclics LLC., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | WBRT, MGd |
| Enrollment | 430 |
| Start date | Aug 1, 1998 |
| Primary completion | Sep 1, 2001 |
| Completion | Jun 1, 2005 |
| First posted | Apr 30, 2004 |
| Last update posted | Oct 31, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: